Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study
Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.
Viacyte Receives Funding to Continue Developing Beta Cell Therapies
ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of…
Just Announced: More Affordable Insulin Options for Medicare Beneficiaries Coming Soon
Breakthrough T1D welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options…
Breakthrough T1D Partner: Huge Upsides to Telemedicine
Virtual Visits Can Transform Care and Improve Outcomes for People with T1D
Breakthrough T1D Heads, Virtually, to ADA’s 80th Scientific Sessions
The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather,…
Creativity Drives Impact for Breakthrough T1D’s Rocky Mountain Chapter
Mask-making family raised more than $26,000 for Denver Breakthrough T1D One Walk.
The Power of YES—How to Thrive in Life Despite Diabetes
Author and T1D mom Moira McCarthy shares the secrets to having a family that thrives even after a family member…
Medtronic Panel Discusses Supporting T1D Community During COVID-19
During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community…
Quarantine Life: How Some T1D Families Are Coping
How a few Breakthrough T1D families have been managing the challenges of working from home while home schooling during the…
Meet the Scientist: Local Immune Suppression with a Novel Protein
Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells…
